Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. (Q42996760)
Jump to navigation
Jump to search
scientific article published on 29 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. |
scientific article published on 29 April 2010 |
Statements
1 reference
Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. (English)
1 reference
Masashi Mizokami
1 reference
Yasuhito Tanaka
1 reference
Katsushi Tokunaga
1 reference
Masao Honda
1 reference
Akito Sakai
1 reference
Tatsuya Yamashita
1 reference
Yasunari Nakamoto
1 reference
Eishiro Mizukoshi
1 reference
Yoshio Sakai
1 reference
Taro Yamashita
1 reference
Mikiko Nakamura
1 reference
Takayoshi Shirasaki
1 reference
Katsuhisa Horimoto
1 reference
Shuichi Kaneko
1 reference
Hokuriku Liver Study Group
1 reference
29 April 2010
1 reference
1 reference
Identifiers
1 reference